ScienceDaily

Vitamin C linked to fewer deaths in blood disorder trial

Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.

Por ScienceDaily

1 minuto de lectura
Vitamin C linked to fewer deaths in blood disorder trial
Vitamin C linked to fewer deaths in blood disorder trial

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Medical Science

Perspectivas relacionadas